Ming Luo

机构：Hubei University of Medicine, CNR de la Résistance aux Antibiotiques, Southern Medical University · ORCID：0000-0002-3070-0927

发表论文 46 篇 · 总被引 603 次 · h-index 14

代表论文

• Circular RNA circPOFUT1 enhances malignant phenotypes and autophagy-associated chemoresistance via sequestrating miR-488-3p to activate the PLAG1-ATG12 axis in gastric cancer (2023 · Cell Death and Disease · 被引 31)
• Machine learning models for fast and isothermal hydrothermal liquefaction of biomass: Comprehensive experiment and prediction of various product fraction yields (2023 · Energy Conversion and Management · 被引 27)
• Characterization of pncA Mutations and Prediction of PZA Resistance in Mycobacterium tuberculosis Clinical Isolates From Chongqing, China (2021 · Frontiers in Microbiology · 被引 27)
• A pH-Responsive Drug-Delivery System Based on Apatinib-Loaded Metal-Organic Frameworks for Ferroptosis-Targeted Synergistic Anti-Tumor Therapy (2024 · International Journal of Nanomedicine · 被引 26)
• NORAD-sponged miR-378c alleviates malignant behaviors of stomach adenocarcinoma via targeting NRP1 (2022 · Cancer Cell International · 被引 16)
• Cinobufotalin regulates the USP36/c-Myc axis to suppress malignant phenotypes of colon cancer cells in vitro and in vivo (2024 · Aging · 被引 12)